New findings from a global study showed that 52% of patients with #CrohnsDisease and 44% of patients with #UlcerativeColitis had suboptimal disease control. Hear two of our leaders detail how the unmet medical need in #IBD fuels our R&D efforts to raise the standard of care: https://bit.ly/3CNXQ2D [Video description: AbbVie leaders explain the IBD PODCAST study results and how our R&D teams are working to continue raising the standard of care for patients with immune-mediated diseases.]
Immunology’s Post
More Relevant Posts
-
New findings from a global study showed that 52% of patients with #CrohnsDisease and 44% of patients with #UlcerativeColitis had suboptimal disease control. Hear two of our leaders detail how the unmet medical need in #IBD fuels our R&D efforts to raise the standard of care: https://bit.ly/3ZmduLr [Video description: AbbVie leaders explain the IBD PODCAST study results and how our R&D teams are working to continue raising the standard of care for patients with immune-mediated diseases.]
-
Director-Level Business Strategy & Operations Management Professional | Customer Engagement | Market Research & Analysis | Business Analytics | Project Leadership | Organization Leadership | Global Capability Development
Pharmaceutical innovation continues to inspire, as companies strive to address unmet medical needs and improve patient outcomes. AbbVie’s recent findings on suboptimal disease control in Crohn’s Disease and Ulcerative Colitis highlight the critical role of research and development in raising the standard of care for immune-mediated diseases. Kudos to AbbVie for their ongoing commitment to enhancing the quality of life for patients worldwide. #Pharma #CrohnsDisease #inspiringNEWS
New findings from a global study showed that 52% of patients with #CrohnsDisease and 44% of patients with #UlcerativeColitis had suboptimal disease control. Hear two of our leaders detail how the unmet medical need in #IBD fuels our R&D efforts to raise the standard of care: https://bit.ly/3ZmduLr [Video description: AbbVie leaders explain the IBD PODCAST study results and how our R&D teams are working to continue raising the standard of care for patients with immune-mediated diseases.]
-
Patients with #RareDisease have unique needs. So do #clinicaltrials of rare disease treatments. Learn how a mature #IRT system built by #RTSM experts can help your complex #clinicaldevelopment program succeed. https://lnkd.in/geXuaWBg #ChooseCalyx #Randomization #TrialSupplyManagement #RareDiseaseDay
-
Patients with #RareDisease have unique needs. So do #clinicaltrials of rare disease treatments. Learn how a mature #IRT system built by #RTSM experts can help your complex #clinicaldevelopment program succeed. https://lnkd.in/gdhBvtsZ #ChooseCalyx #Randomization #TrialSupplyManagement
Special Considerations for RTSM in Rare Disease Trials: Part 1
calyx.dsmn8.com
-
Patients with #RareDisease have unique needs. So do #clinicaltrials of rare disease treatments. Learn how a mature #IRT system built by #RTSM experts can help your complex #clinicaldevelopment program succeed. https://lnkd.in/gkDCHP_8 #ChooseCalyx #Randomization #TrialSupplyManagement
Special Considerations for RTSM in Rare Disease Trials: Part 1
calyx.dsmn8.com
-
Patients with #RareDisease have unique needs. So do #clinicaltrials of rare disease treatments. Learn how a mature #IRT system built by #RTSM experts can help your complex #clinicaldevelopment program succeed. https://lnkd.in/gS2SeRSW #ChooseCalyx #Randomization #TrialSupplyManagement
Special Considerations for RTSM in Rare Disease Trials: Part 1
calyx.dsmn8.com
-
Skilled Associate Clinical Data Manager @ CALYX | Data Management / Analyst Education - Masters ( M. Pharm)- Bits-Pilani MBA-Manipal University
Patients with #RareDisease have unique needs. So do #clinicaltrials of rare disease treatments. Learn how a mature #IRT system built by #RTSM experts can help your complex #clinicaldevelopment program succeed. https://lnkd.in/gcEGpAvm #ChooseCalyx #Randomization #TrialSupplyManagement #RareDiseaseDay
Special Considerations for RTSM in Rare Disease Trials: Part 1
calyx.dsmn8.com
-
Patients with #RareDisease have unique needs. So do #clinicaltrials of rare disease treatments. Learn how a mature #IRT system built by #RTSM experts can help your complex #clinicaldevelopment program succeed. https://lnkd.in/gKfJ4Cfa #ChooseCalyx #Randomization #TrialSupplyManagement
Special Considerations for RTSM in Rare Disease Trials: Part 1
calyx.dsmn8.com
-
Patients with #RareDisease have unique needs. So do #clinicaltrials of rare disease treatments. Learn how a mature #IRT system built by #RTSM experts can help your complex #clinicaldevelopment program succeed. https://lnkd.in/gWTEgKa7 #ChooseCalyx #Randomization #TrialSupplyManagement
Special Considerations for RTSM in Rare Disease Trials: Part 1
calyx.dsmn8.com
-
Patients with #RareDisease have unique needs. So do #clinicaltrials of rare disease treatments. Learn how a mature #IRT system built by #RTSM experts can help your complex #clinicaldevelopment program succeed. https://lnkd.in/gktgiZ7b #ChooseCalyx #Randomization #TrialSupplyManagement #RareDiseaseDay
Special Considerations for RTSM in Rare Disease Trials: Part 1
calyx.dsmn8.com
